CNST | Constellation Pharmaceuticals (NASDAQ:CNST) Upgraded to “Buy” by ValuEngine

ValuEngine upgraded shares of Constellation Pharmaceuticals (NASDAQ:CNST) from a hold rating to a buy rating in a research note issued to investors on Friday morning, ValuEngine reports.Several other research analysts also recently commented on the company.Jefferies Financial Group reaffirmed a buy rating on shares of Constellation Pharmaceuticals in a report on Sunday, August […]The Olympia […]